Skip to main content
Erschienen in: International Journal of Hematology 4/2021

02.01.2021 | Original Article

Impact of cGVHD on socioeconomic outcomes in survivors with pediatric hematopoietic stem cell transplant in Japan: a cross-sectional observational study

verfasst von: Takafumi Soejima, Masaaki Shiohara, Yasushi Ishida, Masami Inoue, Akira Hayakawa, Atsushi Sato, Kiyoko Kamibeppu, Yoshiko Atsuta, Takuya Yamashita

Erschienen in: International Journal of Hematology | Ausgabe 4/2021

Einloggen, um Zugang zu erhalten

Abstract

We conducted a cross-sectional observational study investigating socioeconomic status among Japanese survivors of pediatric hematopoietic stem cell transplantation (HCT) and the impact of chronic graft-versus-host disease (cGVHD) on socioeconomic outcomes, which are topics not well explored in the previous research. We collected data on socioeconomic outcomes from 442 HCT survivors through a questionnaire and obtained demographic and clinical information from their attending physicians and a national database between February 2013 and November 2014. We used logistic regression analysis to examine the relationship between cGVHD and socioeconomic outcomes in allogeneic HCT (allo-HCT) survivors. Most survivors did not experience socioeconomic problems. Nevertheless, allo-HCT survivors with cGVHD aged 8–15 years had poorer economic status (p = 0.013), and allo-HCT survivors with cGVHD aged ≥ 16 years were more likely to have never married (p = 0.034) and less likely to have more than a high school education (p = 0.023), compared with allo-HCT survivors without cGVHD. Thus, cGVHD in Japanese allo-HCT survivors was a risk factor for economic difficulties for those aged 8–15 years, and for never marrying and low educational achievement in those aged ≥ 16 years.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat D’Souza A, Lee S, Zhu X, Pasquini M. Current use and trends in hematopoietic cell transplantation in the United States. Biol Blood Marrow Transplant. 2017;23(9):1417–21.CrossRef D’Souza A, Lee S, Zhu X, Pasquini M. Current use and trends in hematopoietic cell transplantation in the United States. Biol Blood Marrow Transplant. 2017;23(9):1417–21.CrossRef
2.
Zurück zum Zitat Copelan EA. Hematopoietic stem-cell transplantation. New Eng J Med. 2006;354(17):1813–26.CrossRef Copelan EA. Hematopoietic stem-cell transplantation. New Eng J Med. 2006;354(17):1813–26.CrossRef
5.
Zurück zum Zitat Chow EJ, Anderson L, Baker KS, Bhatia S, Guilcher GM, Huang JT, et al. Late effects surveillance recommendations among survivors of childhood hematopoietic cell transplantation: a Children’s Oncology Group report. Biol Blood Marrow Transplant. 2016;22(5):782–95.CrossRef Chow EJ, Anderson L, Baker KS, Bhatia S, Guilcher GM, Huang JT, et al. Late effects surveillance recommendations among survivors of childhood hematopoietic cell transplantation: a Children’s Oncology Group report. Biol Blood Marrow Transplant. 2016;22(5):782–95.CrossRef
6.
Zurück zum Zitat Socié G, Ritz J. Current issues in chronic graft-versus-host disease. Blood. 2014;124(3):374–84.CrossRef Socié G, Ritz J. Current issues in chronic graft-versus-host disease. Blood. 2014;124(3):374–84.CrossRef
7.
Zurück zum Zitat Bevans M, El-Jawahri A, Tierney DK, Wiener L, Wood WA, Hoodin F, et al. National Institutes of Health hematopoietic cell transplantation late effects initiative: the patient-centered outcomes working group report. Biol Blood Marrow Transplant. 2017;23(4):538–51.CrossRef Bevans M, El-Jawahri A, Tierney DK, Wiener L, Wood WA, Hoodin F, et al. National Institutes of Health hematopoietic cell transplantation late effects initiative: the patient-centered outcomes working group report. Biol Blood Marrow Transplant. 2017;23(4):538–51.CrossRef
8.
Zurück zum Zitat Fiuza-Luces C, Simpson RJ, Ramírez M, Lucia A, Berger NA. Physical function and quality of life in patients with chronic GvHD: a summary of preclinical and clinical studies and a call for exercise intervention trials in patients. Bone Marrow Transplant. 2016;51(1):13–26.CrossRef Fiuza-Luces C, Simpson RJ, Ramírez M, Lucia A, Berger NA. Physical function and quality of life in patients with chronic GvHD: a summary of preclinical and clinical studies and a call for exercise intervention trials in patients. Bone Marrow Transplant. 2016;51(1):13–26.CrossRef
9.
Zurück zum Zitat Effinger KE, Stratton KL, Fisher PG, Ness KK, Krull KR, Oeffinger KC, et al. Long-term health and social function in adult survivors of paediatric astrocytoma: a report from the Childhood Cancer Survivor Study. Eur J Cancer. 2019;106:171–80.CrossRef Effinger KE, Stratton KL, Fisher PG, Ness KK, Krull KR, Oeffinger KC, et al. Long-term health and social function in adult survivors of paediatric astrocytoma: a report from the Childhood Cancer Survivor Study. Eur J Cancer. 2019;106:171–80.CrossRef
10.
Zurück zum Zitat Frederiksen LE, Mader L, Feychting M, Mogensen H, Madanat-Harjuoja L, Malila N, et al. Surviving childhood cancer: a systematic review of studies on risk and determinants of adverse socioeconomic outcomes. Int J Cancer. 2019;144(8):1796–823.CrossRef Frederiksen LE, Mader L, Feychting M, Mogensen H, Madanat-Harjuoja L, Malila N, et al. Surviving childhood cancer: a systematic review of studies on risk and determinants of adverse socioeconomic outcomes. Int J Cancer. 2019;144(8):1796–823.CrossRef
11.
Zurück zum Zitat Brinkman TM, Recklitis CJ, Michel G, Grootenhuis MA, Klosky JL. Psychological symptoms, social outcomes, socioeconomic attainment, and health behaviors among survivors of childhood cancer: current state of the literature. J Clin Oncol. 2018;36(21):2190–7.CrossRef Brinkman TM, Recklitis CJ, Michel G, Grootenhuis MA, Klosky JL. Psychological symptoms, social outcomes, socioeconomic attainment, and health behaviors among survivors of childhood cancer: current state of the literature. J Clin Oncol. 2018;36(21):2190–7.CrossRef
12.
Zurück zum Zitat Gurney JG, Krull KR, Kadan-Lottick N, Nicholson HS, Nathan PC, Zebrack B, et al. Social outcomes in the childhood cancer survivor study cohort. J Clin Oncol. 2009;27(14):2390–5.CrossRef Gurney JG, Krull KR, Kadan-Lottick N, Nicholson HS, Nathan PC, Zebrack B, et al. Social outcomes in the childhood cancer survivor study cohort. J Clin Oncol. 2009;27(14):2390–5.CrossRef
13.
Zurück zum Zitat Bona K, London WB, Guo D, Abel G, Lehmann L, Wolfe J. Prevalence and impact of financial hardship among New England pediatric stem cell transplantation families. Biol Blood Marrow Transplant. 2015;21(2):312–8.CrossRef Bona K, London WB, Guo D, Abel G, Lehmann L, Wolfe J. Prevalence and impact of financial hardship among New England pediatric stem cell transplantation families. Biol Blood Marrow Transplant. 2015;21(2):312–8.CrossRef
14.
Zurück zum Zitat Freycon F, Trombert-Paviot B, Casagranda L, Frappaz D, Mialou V, Armari-Alla C, et al. Academic difficulties and occupational outcomes of adult survivors of childhood leukemia who have undergone allogeneic hematopoietic stem cell transplantation and fractionated total body irradiation conditioning. Pediatr Hematol Oncol. 2014;31(3):225–36.CrossRef Freycon F, Trombert-Paviot B, Casagranda L, Frappaz D, Mialou V, Armari-Alla C, et al. Academic difficulties and occupational outcomes of adult survivors of childhood leukemia who have undergone allogeneic hematopoietic stem cell transplantation and fractionated total body irradiation conditioning. Pediatr Hematol Oncol. 2014;31(3):225–36.CrossRef
15.
Zurück zum Zitat Löf CM, Winiarski J, Ljungman P, Forinder U. The socioeconomic and psychosocial circumstances of adult long-term survivors of hematopoietic stem cell transplantation in childhood. Pediatr Transplant. 2011;15(7):691–8.CrossRef Löf CM, Winiarski J, Ljungman P, Forinder U. The socioeconomic and psychosocial circumstances of adult long-term survivors of hematopoietic stem cell transplantation in childhood. Pediatr Transplant. 2011;15(7):691–8.CrossRef
16.
Zurück zum Zitat Bhatt NS, Brazauskas R, Tecca HR, Carreras J, Burns LJ, Phelan R, et al. Post-transplantation employment status of adult survivors of childhood allogeneic hematopoietic cell transplant: a report from the Center for International Blood and Marrow Transplant Research (CIBMTR). Cancer. 2019;125(1):144–52.CrossRef Bhatt NS, Brazauskas R, Tecca HR, Carreras J, Burns LJ, Phelan R, et al. Post-transplantation employment status of adult survivors of childhood allogeneic hematopoietic cell transplant: a report from the Center for International Blood and Marrow Transplant Research (CIBMTR). Cancer. 2019;125(1):144–52.CrossRef
17.
Zurück zum Zitat Ishida Y, Honda M, Ozono S, Okamura J, Asami K, Maeda N, et al. Late effects and quality of life of childhood cancer survivors: part 1. Impact of stem cell transplantation. Int J Hematol. 2010;91(5):865–76.CrossRef Ishida Y, Honda M, Ozono S, Okamura J, Asami K, Maeda N, et al. Late effects and quality of life of childhood cancer survivors: part 1. Impact of stem cell transplantation. Int J Hematol. 2010;91(5):865–76.CrossRef
18.
Zurück zum Zitat Ishida Y, Honda M, Kamibeppu K, Ozono S, Okamura J, Asami K, et al. Social outcomes and quality of life of childhood cancer survivors in Japan: a cross-sectional study on marriage, education, employment and health-related QOL (SF-36). Int J Hematol. 2011;93(5):633–44.CrossRef Ishida Y, Honda M, Kamibeppu K, Ozono S, Okamura J, Asami K, et al. Social outcomes and quality of life of childhood cancer survivors in Japan: a cross-sectional study on marriage, education, employment and health-related QOL (SF-36). Int J Hematol. 2011;93(5):633–44.CrossRef
19.
Zurück zum Zitat Ness KK, Mertens AC, Hudson MM, Nagarajan R, Kaste SC, Marina N, et al. Limitations on physical performance and daily activities among long-term survivors of childhood cancer. Ann Intern Med. 2005;143(9):639–47.CrossRef Ness KK, Mertens AC, Hudson MM, Nagarajan R, Kaste SC, Marina N, et al. Limitations on physical performance and daily activities among long-term survivors of childhood cancer. Ann Intern Med. 2005;143(9):639–47.CrossRef
20.
Zurück zum Zitat Ishida Y, Sato I, Inoue M, Hayakawa A, Shiohara M, Sato A, et al. Quality of life of long-term childhood survivors after autologous or allogeneic stem cell transplantation in Japan—a cross-sectional study [English abstract available]. J Hematop Cell Transplant. 2018;7(3):107–12.CrossRef Ishida Y, Sato I, Inoue M, Hayakawa A, Shiohara M, Sato A, et al. Quality of life of long-term childhood survivors after autologous or allogeneic stem cell transplantation in Japan—a cross-sectional study [English abstract available]. J Hematop Cell Transplant. 2018;7(3):107–12.CrossRef
21.
Zurück zum Zitat Atsuta Y, Suzuki R, Yoshimi A, Gondo H, Tanaka J, Hiraoka A, et al. Unification of hematopoietic stem cell transplantation registries in Japan and establishment of the TRUMP System. Int J Hematol. 2007;86(3):269–74.CrossRef Atsuta Y, Suzuki R, Yoshimi A, Gondo H, Tanaka J, Hiraoka A, et al. Unification of hematopoietic stem cell transplantation registries in Japan and establishment of the TRUMP System. Int J Hematol. 2007;86(3):269–74.CrossRef
22.
Zurück zum Zitat Filipovich AH, Weisdorf D, Pavletic S, Socie G, Wingard JR, Lee SJ, et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant. 2005;11(12):945–56.CrossRef Filipovich AH, Weisdorf D, Pavletic S, Socie G, Wingard JR, Lee SJ, et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant. 2005;11(12):945–56.CrossRef
26.
Zurück zum Zitat Keegan TH, Lichtensztajn DY, Kato I, Kent EE, Wu XC, West MM, et al. Unmet adolescent and young adult cancer survivors information and service needs: a population-based cancer registry study. J Cancer Surviv. 2012;6(3):239–50.CrossRef Keegan TH, Lichtensztajn DY, Kato I, Kent EE, Wu XC, West MM, et al. Unmet adolescent and young adult cancer survivors information and service needs: a population-based cancer registry study. J Cancer Surviv. 2012;6(3):239–50.CrossRef
27.
Zurück zum Zitat Goldfarb M, Casillas J. Unmet information and support needs in newly diagnosed thyroid cancer: comparison of adolescents/young adults (AYA) and older patients. J Cancer Surviv. 2014;8(3):394–401.CrossRef Goldfarb M, Casillas J. Unmet information and support needs in newly diagnosed thyroid cancer: comparison of adolescents/young adults (AYA) and older patients. J Cancer Surviv. 2014;8(3):394–401.CrossRef
28.
Zurück zum Zitat Choi SW, Levine JE, Ferrara JL. Pathogenesis and management of graft-versus-host disease. Immunol Allergy Clin N Am. 2010;30(1):75–101.CrossRef Choi SW, Levine JE, Ferrara JL. Pathogenesis and management of graft-versus-host disease. Immunol Allergy Clin N Am. 2010;30(1):75–101.CrossRef
29.
Zurück zum Zitat Sato I, Higuchi A, Yanagisawa T, Murayama S, Kumabe T, Sugiyama K, et al. Employment status and termination among survivors of pediatric brain tumors: a cross-sectional survey. Int J Clin Oncol. 2018;23(5):801–11.CrossRef Sato I, Higuchi A, Yanagisawa T, Murayama S, Kumabe T, Sugiyama K, et al. Employment status and termination among survivors of pediatric brain tumors: a cross-sectional survey. Int J Clin Oncol. 2018;23(5):801–11.CrossRef
Metadaten
Titel
Impact of cGVHD on socioeconomic outcomes in survivors with pediatric hematopoietic stem cell transplant in Japan: a cross-sectional observational study
verfasst von
Takafumi Soejima
Masaaki Shiohara
Yasushi Ishida
Masami Inoue
Akira Hayakawa
Atsushi Sato
Kiyoko Kamibeppu
Yoshiko Atsuta
Takuya Yamashita
Publikationsdatum
02.01.2021
Verlag
Springer Singapore
Erschienen in
International Journal of Hematology / Ausgabe 4/2021
Print ISSN: 0925-5710
Elektronische ISSN: 1865-3774
DOI
https://doi.org/10.1007/s12185-020-03058-7

Weitere Artikel der Ausgabe 4/2021

International Journal of Hematology 4/2021 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.